What question did this study set out to answer?

This research aims to assess the prevalence of multidrug-resistant Shigella and guide antibiotic use.

March 26, 2026Open Access

Shigellosis: antibiotics should be strictly reserved for severe disease and cases at very high risk of onward transmission

Puntos clave

This research aims to assess the prevalence of multidrug-resistant Shigella and guide antibiotic use.
Conducted a retrospective review of shigellosis notifications in Southeast Queensland.
Analyzed the rates of multidrug-resistant and extensively drug-resistant Shigella.
Evaluated the necessary conditions for antimicrobial treatment.
XDR Shigella accounted for 48% of shigellosis notifications observed.
Antimicrobial treatment is recommended only for severe cases, immunocompromised individuals, or those at high risk of transmission.

Resumen

Increasing rates of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Shigella have been detected worldwide. This retrospective review of shigellosis notifications in Southeast Queensland found that XDR Shigella accounted for 48% of notifications. Antimicrobial treatment should be reserved for individuals with severe disease, immunocompromise or high risk of onward transmission.

Me gusta

Guardar

Ver artículo completo